KUALA LUMPUR: Duopharma Biotech Bhd
has appointed Wan Amir-Jeffery Wan Abdul Majid as the company’s group chief executive officer (Group CEO), effective Oct 1, 2025.
Duopharma Biotech chairman Datin Paduka Kartini Abdul Manaf said Wan Amir-Jeffery has contributed immensely to the group strategically and operationally. "I am confident that Duopharma Biotech will continue its healthy growth trajectory, strengthening its position as a leading pharmaceutical company in Malaysia," she said in a statement today.
